Warkentin and Heddle developed a score for the diagnosis of immune heparin-induced thrombocytopenia (HIT). This can help distinguish HIT from conditions that have similar features. The authors are from Hamilton Health Sciences in Ontario, Canada.
Parameters:
(1) platelet count
(2) timing of onset after starting heparin therapy
(3) thrombosis
(4) other causes
decrease in platelet count in percent =
= ((platelet count before) - (platelet count after)) / (platelet count before) * 100%
Parameter |
Finding |
Points |
platelet count |
< 30% drop OR absolute count < 10,000 per µL |
0 |
|
30 - 50% drop OR absolute count 10,000 - 19,000 per µL |
1 |
|
> 50% drop OR absolute count 20,000 - 100,000 per µL |
2 |
timing of onset after starting heparin |
< 5 days without a recent exposure to heparin |
0 |
|
> 10 days after starting heparin |
1 |
|
5 to 10 days after starting heparin |
2 |
|
< 1 day with a recent exposure to heparin |
2 |
thrombosis |
none |
0 |
|
recurrent or progression in thrombus; suspect thrombosis; skin erythema |
1 |
|
new onset of thrombosis; skin necrosis; acute systemic reaction |
2 |
other causes |
definite |
0 |
|
possible |
1 |
|
none |
2 |
where:
• The "absolute count" under platelet count refers to the drop in the platelet count from baseline.
total score =
= SUM(points for all 4 parameters)
Interpretation:
• minimum score: 0
• maximum score: 8
• The higher the score the more likely HIT is present.
Total Score |
Probability of HIT |
<= 3 |
low |
4 or 5 |
intermediate |
>= 6 |
high |
Purpose: To evaluate a patient for heparin-induced thrombocytopenia (HIT) using the diagnostic score of Warkentin and Heddle.
Specialty: Hematology Oncology, Clinical Laboratory, Pharmacology, clinical, Critical Care, Immunology/Rheumatology
Objective: clinical diagnosis, including family history for genetics, laboratory tests, criteria for diagnosis, differential diagnosis and mimics, red flags
ICD-10: D69,